[{"Assets_0_Q1_USD":69181000000.0,"CommonStockSharesConverted_0_Q1_shares":1124000000.0,"EarningsPerShareBasic_1_Q1_USD":1.04,"EarningsPerShareDiluted_1_Q1_USD":1.03,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1496000000.0,"NetIncomeLossConverted_1_Q1_USD":1134000000.0,"RevenuesConverted_1_Q1_USD":5065000000.0,"StockholdersEquity_0_Q1_USD":18621000000.0,"StockholdersEquityConverted_0_Q1_USD":20102000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1017000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20180503"}]